Affinage

FMNL2

Formin-like protein 2 · UniProt Q96PY5

Length
1086 aa
Mass
123.3 kDa
Annotated
2026-04-28
42 papers in source corpus 18 papers cited in narrative 19 extracted findings

Mechanistic narrative

Synthesis pass · prose summary of the discoveries below

FMNL2 is a Diaphanous-related formin that drives actin-dependent membrane dynamics in cell migration, junction formation, intracellular trafficking, and meiotic spindle positioning. It is cotranslationally N-myristoylated at Gly2 and maintained in an autoinhibited state until activated by Cdc42 (or Rac1 at cell–cell junctions), whereupon it targets to lamellipodia/filopodia tips and the Golgi, functioning as a profilin-dependent actin filament elongation factor—not a nucleator—that captures and extends Arp2/3-generated barbed ends (PMID:22608513, PMID:25963737, PMID:28852060, PMID:29579104). At filopodia, FMNL2 cooperates with the I-BAR protein IRTKS to initiate filopodia assembly and directly binds and regulates fascin dynamics, with PKCα-mediated phosphorylation of Ser1072 in the DAD domain providing additional spatiotemporal control (PMID:32294157, PMID:36259517, PMID:36979484). Beyond protrusive structures, FMNL2 assembles a perinuclear actin meshwork at the Golgi required for anterograde trafficking and endosome maturation, drives invadopodium formation through direct interaction with cortactin, promotes oocyte meiotic spindle migration to the cortex, and interacts with SRC kinase to facilitate androgen receptor nuclear translocation (PMID:28852060, PMID:29374558, PMID:38747713, PMID:40212590).

Mechanistic history

Synthesis pass · year-by-year structured walk · 13 steps
  1. 2010 Medium

    Establishing that FMNL2 promotes epithelial-to-mesenchymal transition and invasion in colorectal cancer cells linked it to the TGF-β/Smad3 and MAPK/MEK signaling cascades, providing the first functional context for the gene in cancer cell plasticity.

    Evidence shRNA knockdown and overexpression in CRC cells with EMT marker profiling and kinase inhibitor treatment

    PMID:21071512

    Open questions at the time
    • Mechanism by which FMNL2 activates MAPK/MEK is indirect and unresolved
    • Single lab, no independent replication
    • No demonstration of direct formin-actin activity in this context
  2. 2012 High

    Defining FMNL2 as a profilin-dependent actin filament elongator (not nucleator) that requires cotranslational N-myristoylation and Cdc42 binding for membrane targeting established its core biochemical activity and activation mechanism.

    Evidence TIRF-based in vitro actin polymerization with purified proteins, site-directed mutagenesis (Gly2→Ala, Cdc42-binding mutants), RNAi with quantitative lamellipodium and migration assays in B16-F1 cells

    PMID:22608513 PMID:22790947

    Open questions at the time
    • No structure of the autoinhibited full-length dimer
    • Profilin isoform specificity not determined
    • In vivo kinetics of elongation vs. Arp2/3 cooperation not measured
  3. 2015 High

    Crystal structures of FMNL2 N-terminal domains bound to Cdc42 revealed how all five armadillo repeats and the Rho-GTPase insert helix mediate specificity, and how an umbrella-shaped dimer with six membrane-interaction motifs couples GTPase sensing to membrane association.

    Evidence X-ray crystallography of FMNL1/FMNL2–Cdc42 complexes, mutagenesis of Rac1 to confer Cdc42-like binding with in vivo rescue

    PMID:25963737

    Open questions at the time
    • No structure capturing the transition from autoinhibited to active state
    • Structural basis for Rac1 activation at junctions vs. Cdc42 activation at filopodia unresolved
  4. 2017 High

    Demonstrating that FMNL2 localizes to the Golgi in a myristoylation- and Cdc42-dependent manner and is required for Golgi integrity, endosome maturation, and anterograde trafficking expanded its role from a lamellipodia/filopodia factor to a central organizer of membrane traffic.

    Evidence RNAi and CRISPR/Cas9 KO with live-cell VSV-G trafficking, Golgi fragmentation, and endosome analysis

    PMID:28852060

    Open questions at the time
    • Identity of actin structures assembled at the Golgi not fully resolved
    • Whether FMNL2 acts at the Golgi independently of FMNL3 is unclear
  5. 2017 High

    Identification of COMMD10 as a direct FMNL2 binding partner whose ubiquitin-mediated degradation by FMNL2 de-represses NF-κB/p65 signaling revealed a non-canonical signaling function beyond actin assembly.

    Evidence Co-IP, GST pull-down, in vitro ubiquitination assay, NF-κB reporter, nuclear fractionation, in vivo metastasis model

    PMID:28817833

    Open questions at the time
    • Whether FMNL2 itself has E3 ligase activity or recruits an E3 ligase is not resolved
    • Relevance outside colorectal cancer not tested
  6. 2018 High

    Showing that cortactin directly binds FMNL2 and cooperatively enhances actin polymerization for invadopodia formation and recycling endosome motility linked the formin to matrix degradation-competent structures.

    Evidence Reciprocal Co-IP, GST pull-down, actin polymerization assays, invadopodia and gelatin degradation assays, live-cell endosome tracking

    PMID:29374558

    Open questions at the time
    • Binding interface between cortactin and FMNL2 not mapped
    • Whether cortactin relieves autoinhibition or acts allosterically is unknown
  7. 2018 High

    Demonstrating that FMNL2 mediates Rac1-dependent cell–cell junction formation independently of Cdc42 established a second Rho-GTPase activation axis for the formin in a distinct cellular context.

    Evidence CRISPR/Cas9 KO in MCF10A cells, optogenetic Rac1 activation with live-cell junction imaging, Cdc42 RNAi epistasis

    PMID:29579104

    Open questions at the time
    • How Rac1 structurally activates FMNL2 given the Cdc42-specific insert helix contacts is unknown
    • Downstream actin structures at nascent junctions not characterized
  8. 2020 High

    Live-cell FRET biosensor imaging revealed that FMNL2 directly binds dephosphorylated fascin in filopodia and controls fascin dynamics at nanoscale resolution, linking the formin to actin-bundling regulation.

    Evidence FRET-based fascin biosensor, SIM/TIRF-SIM, Co-IP, RNAi

    PMID:32294157

    Open questions at the time
    • Whether FMNL2 directly modulates fascin phosphorylation or acts via kinase/phosphatase recruitment is unresolved
    • Binding interface between FMNL2 and fascin not mapped
  9. 2021 Medium

    Upregulation of FMNL2 upon Arp2/3 complex depletion, coinciding with explosive filopodia induction, revealed a compensatory relationship between branched and unbranched actin networks.

    Evidence Conditional CRISPR/Cas9 Actr3 KO, immunoblotting, quantitative filopodia analysis

    PMID:33598464

    Open questions at the time
    • Transcriptional vs. post-translational mechanism of FMNL2 upregulation not determined
    • Single cell system (B16-F1)
    • Functional requirement of FMNL2 for the filopodia phenotype not directly tested by double KO
  10. 2022 Medium

    Showing that FMNL2 cooperates with the I-BAR protein IRTKS (not IRSp53) for filopodia assembly, with FMNL2's primary role being membrane recruitment of IRTKS rather than FH2-mediated actin elongation, reframed FMNL2 as a membrane-targeting scaffold in filopodia initiation.

    Evidence Co-IP, co-expression, filopodia quantification, RNAi of IRTKS/IRSp53, domain mutagenesis

    PMID:36259517

    Open questions at the time
    • Single lab; IRTKS–FMNL2 interface not structurally resolved
    • Relative contributions of membrane binding vs. actin elongation not quantified in vivo
  11. 2023 Medium

    Identification of PKCα-mediated Ser1072 phosphorylation in the DAD domain as required for rapid filopodia formation uncovered a post-translational regulatory layer controlling FMNL2 activation kinetics.

    Evidence Phospho-site mutagenesis (S1072A), PKCα inhibition and knockdown, SIM live-cell imaging

    PMID:36979484

    Open questions at the time
    • Whether S1072 phosphorylation relieves autoinhibition or promotes a distinct conformational change is untested
    • In vitro kinase assay for direct PKCα phosphorylation of S1072 not shown
    • Single lab
  12. 2024 High

    Demonstrating that FMNL2 drives cytoplasmic actin polymerization required for meiotic spindle migration to the oocyte cortex, with its depletion causing polar body extrusion defects and mitochondrial/ER stress, extended the formin's function to female gamete maturation.

    Evidence Morpholino/siRNA knockdown in mouse and porcine oocytes, mRNA rescue, live-cell imaging, mass spectrometry proteomics, JC-1 assay

    PMID:38747713

    Open questions at the time
    • Whether FMNL2 directly organizes mitochondrial/ER membranes or the stress is secondary to actin disorganization is unclear
    • Upstream activating GTPase in oocytes not identified
  13. 2025 Medium

    Discovery that FMNL2 directly interacts with SRC kinase (FH1–SH3 domains) to promote androgen receptor nuclear translocation and enzalutamide resistance revealed a kinase-scaffolding function in hormone signaling.

    Evidence Co-IP with domain mapping, nuclear fractionation, AR reporter, dasatinib treatment, RNAi

    PMID:40212590

    Open questions at the time
    • Whether the FMNL2–SRC interaction is actin-dependent or independent is not tested
    • Single cancer cell system (prostate)
    • No structural model of the FH1–SH3 interaction

Open questions

Synthesis pass · forward-looking unresolved questions
  • A full-length structure of autoinhibited and activated FMNL2 dimer, the mechanism by which FMNL2 promotes COMMD10 ubiquitination, whether PKCα directly phosphorylates S1072 in vitro, and how Rac1 achieves activation despite the Cdc42-specific structural contacts remain unresolved.
  • No full-length structure
  • E3 ligase identity for COMMD10 degradation unknown
  • Direct PKCα–FMNL2 kinase reaction not reconstituted
  • Rac1 activation mechanism structurally unresolved

Mechanism profile

Synthesis pass · controlled-vocabulary classification · explore literature graph →
Molecular activity
GO:0008092 cytoskeletal protein binding 3 GO:0060090 molecular adaptor activity 2
Localization
GO:0005856 cytoskeleton 3 GO:0005886 plasma membrane 3 GO:0005829 cytosol 2 GO:0031410 cytoplasmic vesicle 2 GO:0005794 Golgi apparatus 1
Pathway
R-HSA-162582 Signal Transduction 3 R-HSA-5653656 Vesicle-mediated transport 2 R-HSA-1474165 Reproduction 1 R-HSA-1500931 Cell-Cell communication 1 R-HSA-1640170 Cell Cycle 1

Evidence

Reading pass · 19 per-paper findings extracted from the source corpus
Year Finding Method Journal Conf PMIDs
2012 FMNL2 is cotranslationally modified by N-terminal myristoylation, which together with interaction with active Cdc42, is required for proper subcellular targeting to lamellipodia and filopodia tips. Abolition of myristoylation or Cdc42 binding prevents FMNL2 activation and membrane targeting. Site-directed mutagenesis (Gly2→Ala to block myristoylation, Cdc42-binding mutants), immunofluorescence, RNAi knockdown Current Biology High 22608513
2012 FMNL2 acts as an actin filament elongation factor (not nucleator) in the presence of profilin in vitro, and can capture and elongate filament ends generated by Arp2/3-mediated branching. RNAi-mediated silencing decreases lamellipodia protrusion rate and cell migration efficiency. In vitro actin polymerization/TIRF assays with purified proteins, RNAi knockdown with quantitative lamellipodium protrusion and migration assays Current Biology High 22608513
2015 Crystal structures of the N-terminal domains of human FMNL1 and FMNL2 in complex with active Cdc42 reveal that Cdc42 contacts all five armadillo repeats of the formin, with specific interactions formed by the Rho-GTPase insert helix. Mutation of three residues in Rac1 confers gain-of-function FMNL2 binding and reconstitutes the Cdc42 phenotype in vivo. FMNL dimerization via a parallel coiled coil creates an umbrella-shaped structure spanning >15 nm with six membrane interaction motifs. X-ray crystallography, site-directed mutagenesis of Rac1/Cdc42 switch residues, in vivo functional rescue assays Nature Communications High 25963737
2012 N-myristoylation at Gly2 of FMNL2 is required for plasma membrane association and for the induction of cellular morphological changes; replacement of Gly2 with Ala or pharmacological inhibition of N-myristoyltransferase abolishes membrane localization and morphological effects. Site-directed mutagenesis (Gly2→Ala), N-myristoylation inhibitor treatment, immunofluorescence in HEK293T cells Bioscience, Biotechnology, and Biochemistry High 22790947
2017 FMNL2 and FMNL3 accumulate at the Golgi apparatus in a manner requiring both N-terminal myristoylation and interaction with Cdc42. At the Golgi, they assemble a perinuclear actin meshwork; their depletion by RNAi or CRISPR/Cas9 causes Golgi fragmentation, enlargement of endosomes, defective maturation into late endosomes/lysosomes, and impaired anterograde trafficking of VSV-G to the plasma membrane. RNAi, CRISPR/Cas9 knockout, live-cell imaging of VSV-G trafficking, immunofluorescence, myristoylation and Cdc42-binding mutants Scientific Reports High 28852060
2010 FMNL2 knockdown in colorectal carcinoma cells induces an epithelial-state transition (cobblestone morphology, upregulation of E-cadherin/α-catenin/γ-catenin, downregulation of vimentin/snail/slug) and abolishes TGF-β-induced invasion and EMT. FMNL2 promotes EMT via TGF-β/Smad3 effectors and in collaboration with MAPK/MEK pathway; MEK inhibitor U0126 abrogates elevated p-MAPK/p-MEK in FMNL2-overexpressing cells. shRNA knockdown, overexpression, morphological analysis, Western blotting for EMT markers, kinase inhibitor treatment (U0126, LY294002), TGF-β stimulation assays Molecular Cancer Research Medium 21071512
2017 FMNL2 physically interacts with COMMD10 (by Co-IP and GST pull-down) and promotes its ubiquitin-mediated proteasomal degradation. Loss of COMMD10 releases p65 NF-κB from inhibition, allowing nuclear translocation of p65 and activation of the NF-κB pathway to promote CRC invasion and metastasis. Co-immunoprecipitation, GST pull-down, in vitro ubiquitination assay, dual-luciferase NF-κB reporter, nuclear fractionation, Western blotting, animal metastasis models British Journal of Cancer High 28817833
2018 Cortactin directly binds FMNL2 and cooperatively enhances actin polymerization and recycling endosome motility. This cortactin–FMNL2 interaction is required for invadopodia formation and matrix degradation in colorectal cancer cells; EGF/Cdc42 stimulation further enhances the cortactin–FMNL2 complex to increase invadopodia number and matrix degradation. Co-immunoprecipitation, GST pull-down, actin polymerization assays, live-cell imaging of endosome motility, invadopodia formation assays, gelatin matrix degradation assay, in vivo metastasis model Cancer Letters High 29374558
2020 FMNL2 directly binds dephosphorylated fascin within filopodia and controls fascin dynamics (phosphorylation state, F-actin binding, localization) at the nanoscale in both 2D and 3D environments, as shown by a fascin FRET biosensor and advanced live-cell imaging. FRET-based fascin biosensor, structured illumination microscopy, TIRF-SIM, co-immunoprecipitation, RNAi knockdown, live-cell imaging Journal of Cell Biology High 32294157
2021 Induced depletion of Arp2/3 complex (Actr3 knockout) reproducibly increases FMNL2 and FMNL3 formin expression, which correlates with explosive induction of filopodia formation, revealing a compensatory or co-regulatory relationship between branched (Arp2/3) and unbranched (FMNL2/3) actin networks. Conditional CRISPR/Cas9 Actr3 knockout (tamoxifen-inducible), immunoblotting, live-cell imaging, quantitative filopodia analysis Frontiers in Cell and Developmental Biology Medium 33598464
2018 FMNL2 mediates cell-cell contact formation downstream of Rac1, independently of Cdc42. CRISPR/Cas9 loss of FMNL2 in MCF10A cells impairs intercellular contact establishment; optogenetic Rac1 activation recruits FMNL2 to newly forming junctions, whereas Cdc42 silencing does not affect FMNL2-mediated contact formation. CRISPR/Cas9 knockout, optogenetic Rac1 activation, live-cell imaging of junction formation, RNAi, quantitative protrusion analysis PLoS ONE High 29579104
2023 FMNL2-dependent rapid filopodia formation requires both N-terminal myristoylation (for filopodia tip localization) and serine 1072 phosphorylation within the DAD domain by PKCα. PKCα localizes to the base of growing filopodia and a PKCα-FMNL2 signaling module spatiotemporally controls filopodia dynamics. Structured illumination microscopy, phospho-site mutagenesis (S1072A), PKCα inhibition/knockdown, live-cell imaging, immunofluorescence co-localization Biomolecules Medium 36979484
2021 A disease-associated heterozygous FMNL2 p.L136P mutation causes subcellular mislocalization, deregulated autoinhibition (gain-of-function), impaired cell spreading, defective filopodia formation in fibroblasts, and dysregulated podosome formation with defective matrix degradation in THP-1 macrophages. Expression of L136P mutant vs. wild-type in patient-derived and model cell lines, immunofluorescence localization, cell spreading assay, filopodia quantification, podosome formation, gelatin degradation assay PLoS ONE Medium 34043722
2022 FMNL2 cooperates with the I-BAR domain protein IRTKS (but not IRSp53) to drive filopodia assembly. FMNL2 and IRTKS are mutually dependent cofactors; the primary function of FMNL2 in this process is membrane binding to recruit IRTKS, which then nucleates filopodia assembly, while FH2-mediated actin dynamics is secondary. Co-immunoprecipitation, co-expression studies, filopodia quantification, RNAi knockdown of IRTKS/IRSp53, domain mutagenesis Journal of Biological Chemistry Medium 36259517
2024 FMNL2 localizes to the oocyte cortex and spindle periphery during meiosis; its depletion reduces cytoplasmic actin polymerization, causes failure of meiotic spindle migration to the cortex, leading to polar body extrusion defects and large polar bodies. FMNL2 also associates with mitochondria and ER-related proteins (by mass spectrometry), and its depletion disrupts mitochondrial membrane potential and causes ER stress. Morpholino/siRNA knockdown in mouse and porcine oocytes, live-cell imaging, immunofluorescence, mass spectrometry proteomics, mRNA rescue microinjection, JC-1 mitochondrial membrane potential assay eLife High 38747713
2024 Proximity labeling proteomics (BioID) identified an FMNL2 interactome including known partners and novel interactors related to filopodia, lamellipodia, vesicle trafficking, cell junctions, focal adhesions, and extracellular vesicles; FMNL2 protein was directly detected in exosomes. BioID proximity labeling, quantitative mass spectrometry proteomics, exosome isolation and Western blotting International Journal of Molecular Sciences Medium 38891874
2025 FMNL2 directly interacts with SRC kinase through the FMNL2-FH1 domain and SRC-SH3 domain, and this interaction promotes androgen receptor (AR) translocation from cytoplasm to nucleus, increasing AR target gene expression and driving enzalutamide resistance in prostate cancer cells. Co-immunoprecipitation, domain mapping, nuclear fractionation, AR reporter assays, RNAi knockdown, SRC inhibitor (dasatinib) treatment, proliferation assays iScience Medium 40212590
2020 CAV1 (Caveolin-1) modulates collective epithelial cell migration by controlling cortical availability of FMNL2; CAV1 depletion increases cortical recruitment of FMNL2, and simultaneous depletion of FMNL2 rescues the migration defect caused by CAV1 RNAi, placing FMNL2 downstream of CAV1 in collective migration. RNAi (CAV1 and FMNL2 single and double knockdown), collective migration velocity correlation analysis, immunofluorescence Biology of the Cell Medium 33169848
2022 FMNL2 suppresses breast cancer cell migration and invasion by inhibiting the RhoA/LIMK/Cofilin pathway, and this effect is mediated through reduction of cytoplasmic p27. ERα overexpression reduces FMNL2 protein levels via proteasomal degradation (blocked by MG132). RNAi knockdown, overexpression, Rho inhibitor (ZOL) and LIMK inhibitor (BMS3) treatment, Western blotting for RhoA/LIMK/Cofilin, cytoplasmic p27 manipulation, MG132 proteasome inhibition, in vivo xenograft Cell Death Discovery Medium 35379791

Source papers

Stage 0 corpus · 42 papers · ranked by NIH iCite citations
Year Title Journal Citations PMID
2012 FMNL2 drives actin-based protrusion and migration downstream of Cdc42. Current biology : CB 172 22608513
2003 Identification and characterization of human FMNL1, FMNL2 and FMNL3 genes in silico. International journal of oncology 128 12684686
2012 MicroRNA-137, an HMGA1 target, suppresses colorectal cancer cell invasion and metastasis in mice by directly targeting FMNL2. Gastroenterology 117 23201162
2008 Overexpression of FMNL2 is closely related to metastasis of colorectal cancer. International journal of colorectal disease 72 18665374
2015 The structure of FMNL2-Cdc42 yields insights into the mechanism of lamellipodia and filopodia formation. Nature communications 69 25963737
2015 MicroRNA-206 functions as a tumor suppressor in colorectal cancer by targeting FMNL2. Journal of cancer research and clinical oncology 60 26515696
2010 FMNL2 enhances invasion of colorectal carcinoma by inducing epithelial-mesenchymal transition. Molecular cancer research : MCR 56 21071512
2011 FMNL2 is a positive regulator of cell motility and metastasis in colorectal carcinoma. The Journal of pathology 48 21506128
2015 MicroRNA-34a targets FMNL2 and E2F5 and suppresses the progression of colorectal cancer. Experimental and molecular pathology 40 26103003
2021 Induced Arp2/3 Complex Depletion Increases FMNL2/3 Formin Expression and Filopodia Formation. Frontiers in cell and developmental biology 35 33598464
2022 FMNL2 regulates gliovascular interactions and is associated with vascular risk factors and cerebrovascular pathology in Alzheimer's disease. Acta neuropathologica 34 35608697
2017 FMNL2 destabilises COMMD10 to activate NF-κB pathway in invasion and metastasis of colorectal cancer. British journal of cancer 34 28817833
2017 FMNL2 and -3 regulate Golgi architecture and anterograde transport downstream of Cdc42. Scientific reports 32 28852060
2017 Long non-coding RNA TUG1 promotes progression of oral squamous cell carcinoma through upregulating FMNL2 by sponging miR-219. American journal of cancer research 32 28979812
2012 Protein N-myristoylation is required for cellular morphological changes induced by two formin family proteins, FMNL2 and FMNL3. Bioscience, biotechnology, and biochemistry 32 22790947
2016 MicroRNA-613 targets FMNL2 and suppresses progression of colorectal cancer. American journal of translational research 30 28078018
2010 Characterization of Diaphanous-related formin FMNL2 in human tissues. BMC cell biology 30 20633255
2018 A novel long noncoding RNA, LINC00483 promotes proliferation and metastasis via modulating of FMNL2 in CRC. Biochemical and biophysical research communications 28 30594388
2016 FMNL2/FMNL3 formins are linked with oncogenic pathways and predict melanoma outcome. The journal of pathology. Clinical research 28 27499915
2020 FMNL2 regulates dynamics of fascin in filopodia. The Journal of cell biology 27 32294157
2018 Cortactin recruits FMNL2 to promote actin polymerization and endosome motility in invadopodia formation. Cancer letters 26 29374558
2019 LINC00707 promotes cell proliferation and invasion of colorectal cancer via miR-206/FMNL2 axis. European review for medical and pharmacological sciences 19 31115001
2018 KIT, NRAS, BRAF and FMNL2 mutations in oral mucosal melanoma and a systematic review of the literature. Oncology letters 15 29805686
2018 A Rac1-FMNL2 signaling module affects cell-cell contact formation independent of Cdc42 and membrane protrusions. PloS one 14 29579104
2016 A specific FMNL2 isoform is up-regulated in invasive cells. BMC cell biology 14 27578625
2024 FMNL2 regulates actin for endoplasmic reticulum and mitochondria distribution in oocyte meiosis. eLife 13 38747713
2022 circRNA TCFL5 Promote Esophageal Cancer Progression by Modulating M2 Macrophage Polarization via the miR-543-FMNL2 Axis. Journal of oncology 13 35646112
2022 Cooperative assembly of filopodia by the formin FMNL2 and I-BAR domain protein IRTKS. The Journal of biological chemistry 12 36259517
2019 MicroRNA-22 targets FMNL2 to inhibit melanoma progression via the regulation of the Wnt/β-catenin signaling pathway and epithelial-mesenchymal transition. European review for medical and pharmacological sciences 11 31298385
2022 LINC00839 promotes malignancy of liver cancer via binding FMNL2 under hypoxia. Scientific reports 9 36335129
2023 Spatiotemporal Regulation of FMNL2 by N-Terminal Myristoylation and C-Terminal Phosphorylation Drives Rapid Filopodia Formation. Biomolecules 8 36979484
2008 [Expression of FMNL2 and its relation to the metastatic potential of human colorectal cancer cells]. Nan fang yi ke da xue xue bao = Journal of Southern Medical University 8 18971169
2021 Characterization of a L136P mutation in Formin-like 2 (FMNL2) from a patient with chronic inflammatory bowel disease. PloS one 7 34043722
2020 TCP11L2 promotes bovine skeletal muscle-derived satellite cell migration and differentiation via FMNL2. Journal of cellular physiology 7 32017087
2022 FMNL2 suppresses cell migration and invasion of breast cancer: a reduction of cytoplasmic p27 via RhoA/LIMK/Cofilin pathway. Cell death discovery 6 35379791
2021 MiR-466 Inhibits the Progression of Severe Hepatocellular Carcinoma via Regulating FMNL2-Mediated Activation of NF-κB and Wnt/β-Catenin Pathways. Journal of oncology 6 34257650
2020 Caveolin-1 influences epithelial collective cell migration via FMNL2 formin. Biology of the cell 6 33169848
2017 FMNL2 with Functions Related to the Cytoskeleton is Partially Regulated by PAX6. Journal of ophthalmic & vision research 4 29090051
2025 FMNL2/SRC-mediated androgen receptor translocation into the nucleus promotes enzalutamide resistance of prostate cancer. iScience 0 40212590
2025 The formin FMNL2 plays a role in the response of melanoma cells to substrate stiffness. BMC molecular and cell biology 0 40301744
2024 Identification of an FMNL2 Interactome by Quantitative Mass Spectrometry. International journal of molecular sciences 0 38891874
2023 [Effect of miR-22 Targeting FMNL2 on Cell Migration and Apoptosis in Childhood Acute Myeloid Leukemia]. Zhongguo shi yan xue ye xue za zhi 0 38071036